Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy

Completed · Phase 3 · Has a placebo group

Conditions studied: HIV Infections, Peripheral Neuropathy

In brief

Study to determine if pregabalin is more effective than placebo in treating subjects with nerve pain associated with HIV neuropathy.

Key facts

Study ID

NCT00232141

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

302

Starts

2005-10-01

Expected to finish

2007-11-01

Last updated by the study team

2021-02-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with confirmed diagnosis of HIV infection
• HIV-associated neuropathic pain (nerve pain) for at least 3 months prior to study start
• subjects with moderate to severe pain
• subjects on stable HIV and pain medications (some medications are not allowed to be taken while participating in the study).

You may not qualify if…

• Pregnant or breast feeding females
• subjects using street drugs or alcohol abusers during the study
• subject's on anti-diabetic medications
• use of neuroregenerative agents or neurotoxic chemotherapeutic agents 3 months prior to study start and throughout the study
• use of neurotoxic drugs (other than D-drugs) within a month prior to study start and throughout the study.

Where it is running

• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Little Rock, Arkansas, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — Sacramento, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — San Francisco, California, United States
• Pfizer Investigational Site — Stanford, California, United States
• Pfizer Investigational Site — West Hollywood, California, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Pensacola, Florida, United States
• Pfizer Investigational Site — Safety Harbor, Florida, United States
• Pfizer Investigational Site — Vero Beach, Florida, United States
• Pfizer Investigational Site — West Palm Beach, Florida, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Honolulu, Hawaii, United States
• Pfizer Investigational Site — Chicago, Illinois, United States
• Pfizer Investigational Site — Chicago, Illinois, United States
• Pfizer Investigational Site — Baltimore, Maryland, United States
• Pfizer Investigational Site — Boston, Massachusetts, United States
• Pfizer Investigational Site — Springfield, Massachusetts, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.